Aurobindo Pharma Limited Aurobindo Pharma Limited

Aurobindo Pharma Limited

AUROPHARMA

Rangering i aksjer #2068
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Aksjekurs
$17.34
Markedsverdi
$9.98B
Endring (1 dag)
-3.08%
Endring (1 år)
38.71%
Land
IN
Handel Aurobindo Pharma Limited (AUROPHARMA)

Kategori

Healthcare
Utbytteavkastning for Aurobindo Pharma Limited (AUROPHARMA)
Aurobindo Pharma Limited (aksjesymbol: AUROPHARMA) sin utbytteavkastning (TTM) per 2024-03-31 er: 0.40%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.59%
Utbytteavkastning for Aurobindo Pharma Limited (AUROPHARMA) fra 2004 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
2026 (TTM) 0.00% -100.00%
2025 0.00% -100.00%
2024 0.40% -72.41%
2023 1.45% 116.42%
2022 0.67% 48.89%
2021 0.45% -38.36%
2020 0.73% 135.48%
2019 0.31% -50.79%
2018 0.63% 117.24%
2017 0.29% -6.45%
2016 0.31% -27.91%
2015 0.43% 7.50%
2014 0.40% -73.68%
2013 1.52% 55.10%
2012 0.98% 16.67%
2011 0.84% 50.00%
2010 0.56% -85.60%
2009 3.89% 285.15%
2008 1.01% 288.46%
2007 0.26% 225.00%
2006 0.08% -91.01%
2005 0.89% 78.00%
2004 0.50% 0.00%
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter